TransMedics Group Inc (TMDX)
Receivables turnover
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Revenue | US$ in thousands | 441,540 | 241,623 | 93,459 | 30,262 | 25,639 |
Receivables | US$ in thousands | — | — | — | — | — |
Receivables turnover | — | — | — | — | — |
December 31, 2024 calculation
Receivables turnover = Revenue ÷ Receivables
= $441,540K ÷ $—K
= —
The data provided indicates that TransMedics Group Inc did not disclose its receivables turnover ratio for the years between December 31, 2020, and December 31, 2024. This lack of information makes it challenging to assess the effectiveness of the company in collecting outstanding receivables within a specific period. As a result, it is not possible to analyze the trend and efficiency of TransMedics' receivables management over the specified years.
Peer comparison
Dec 31, 2024
Company name
Symbol
Receivables turnover
TransMedics Group Inc
TMDX
—
BioLife Solutions Inc
BLFS
10.69
CONMED Corporation
CNMD
—
LivaNova PLC
LIVN
6.33
Masimo Corporation
MASI
104.08
Medtronic PLC
MDT
—